13.11.2024  22:20:59 Zm. -1,10 Wolumen Bid22:20:59 Ask22:20:59 Kapitalizacja Rynkowa St. dywidendy Wskaźnik C/Z
78,40EUR -1,38% -
Obrót: -
78,40Wolumen Bid: - 79,40Wolumen Ask: - 5,96 mldEUR - -

Opis działalności

Bachem is a listed technology-based company focused on peptide chemistry. The company provides a full range of services to the pharma and biotech industries. It specializes in the development of innovative, efficient manufacturing processes and the reliable production of peptide-based active pharmaceutical ingredients. A comprehensive catalog of biochemicals and exclusive custom syntheses for research labs complete the service portfolio. Headquartered in Switzerland with subsidiaries in Europe and the US, the group has a global reach with more experience and know-how than any other company in the industry. Towards its customers, Bachem shows total commitment to quality, innovation and partnership.
 

Zarząd & Rada nadzorcza

CEO
Thomas Meier
Zarząd
Alain Schaffter, Dr. Günther Loidl, Torsten Wohr
Rada nadzorcza
Dr. Kuno Sommer, Nicole Grogg Hötzer, Dr. Alex Fässler, Dr. Steffen Lang, Prof. Dr. Helma Wennemers, Dr. h.c. Peter Grogg
 

Dane firmy

Nazwa: Bachem Holding AG
Adres: Hauptstraße 144,CH-4416 Bubendorf
Telefon: +41-58-595-2020
Fax: +41-58-595-2040
E-mail: sales.ch@bachem.com
Internet: www.bachem.com
Przemysł: Surowce naturalne
Sektor: Chemia
Podsektor: Chemia, Specjalizacja
Koniec roku finansowego: 31.12
Free float: 38,00%
Data IPO: 22.07.1998

Relacje inwestorskie

Nazwa: Daniel Grotzky
Telefon: +41-58-595-2021
Fax: +41-58-595-2043
E-mail: ir@bachem.com

Główni akcjonariusze

a Ingro Finanz AG
 
52,10%
Inne
 
42,50%
Peter and Madeleine Grogg
 
5,40%